Articles Referencing DNDN

Zacks.com

Bayer's Xofigo Cleared in the US - Analyst Blog

Bayer 's ( BAYRY ) HealthCare segment recently received encouraging news as the US Food and Drug Administration (FDA) approved its oncology drug Xofigo (radium 223 dichloride). Xofigo was... Read >>

Zacks.com

Dendreon Narrows 1Q Loss - Analyst Blog

Dendreon Corporation ( DNDN ) reported first-quarter 2013 loss (including stock-based compensation expenses) of 37 cents per share, narrower than the Zacks Consensus Estimate of a loss of... Read >>

NASDAQ.com News

Pre-Market Most Active for May 10, 2013 : DELL, DDD, APO, NOK, BAC, ING, NVS, PTIE, DNDN, NVDA, ERIC, MU

The NASDAQ 100 Pre-Market Indicator is up 2.22 to 2,963.34. The total Pre-Market volume is currently 29,565,527 shares traded. The following are the most active stocks for the pre-market... Read >>

Benzinga

Mid-Day Market Update: Precision Castparts Rises as Rackspace Plummets

Midway through trading Thursday, the Dow traded down 0.01 percent to 15,104.07 while the NASDAQ rose 0.05 percent to 3,414.18. The S&P also fell, decreasing 0.19 percent to 1,629.25. ... Read >>

Benzinga

Mid-Morning Market Update: Tesla Soars on Earnings as LivePerson Gets Crushed

Following the market opening Thursday, the Dow traded down 0.09 percent to 15,092.07 while the NASDAQ fell 0.07 percent to 3,411.18. The S&P also fell, decreasing 0.23 percent... Read >>

NASDAQ.com News

After Hours Most Active for Apr 19, 2013 : PBR/A, CRM, PPL, DOW, GILD, MS, QQQ, EMC, DTV, DNDN, SQNM, YHOO

The NASDAQ 100 After Hours Indicator is down -1.75 to 2,778.71. The total After hours volume is currently 33,716,080 shares traded. The following are the most active stocks for the after... Read >>

SeekingAlpha

ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107

By Smith On Stocks : Investment Thesis It is my hypothesis that dendritic cell cancer vaccines have the promise to be a major advance in cancer therapy. In October of 2011, Dr. Ralph... Read >>

Zacks.com

Dendreon Reports Narrower Loss - Analyst Blog

Dendreon Corporation ( DNDN ) reported fourth-quarter 2012 loss (including stock-based compensation expenses) of 40 cents per share, narrower than the Zacks Consensus Estimate of a loss of... Read >>

NASDAQ.com News

Pre-Market Earnings Report for February 25, 2013 : LOW, FE, HTZ, DCI, KOS, ARIA, DDD, BGC, CTB, CWH, HL, DNDN

The following companies are expected to report earnings prior to market open on 02/25/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Lowe's Companies, Inc. ... Read >>

Zacks.com

Priority Review for Bayer's Drug - Analyst Blog

The HealthCare unit of Bayer AG ( BAYRY ) recently announced that the US Food and Drug Administration (FDA) granted priority review to the New Drug Application (NDA) for its... Read >>

StreetAuthority

This Small-Cap Biotech Could be Your Ticket to 91% Profits

Biotech stocks have a history of volatile moves, but the swings in this issue could make the calmest trader seasick. Between April 2009 and April 2010, biotech stock Dendreon (Nasdaq: DNDN) ... Read >>

Melvin Pasternak

This Small-Cap Biotech Could be Your Ticket to 91% Profits

Biotechstocks have a history of volatile moves, but the swings in thisissue could make the calmest trader seasick. Between April 2009 and April 2010, biotechstock Dendreon (Nasdaq: DNDN ) ... Read >>

Benzinga

One Biotech Stock Investors are Unfairly Ignoring

Shares of biotech company Halozyme Therapeutics (NASDAQ: HALO ) were unchanged in pre-market trading on Tuesday following Monday's gain of more than 15 percent. Investors bid up the stock... Read >>

NASDAQ.com News

Pre-Market Most Active for Jan 14, 2013 : NOK, MT, FB, AAPL, ING, BAC, RIMM, S, DNDN, F, QQQ, ZNGA

The NASDAQ 100 Pre-Market Indicator is down -11.62 to 2,736.64. The total Pre-Market volume is currently 4,265,488 shares traded. The following are the most active stocks for the... Read >>

NASDAQ.com News

Pre-Market Most Active for Jan 11, 2013 : MT, BAC, WFC, NOK, DNDN, BBY, SAP, FB, RIMM, SIRI, AAPL, ARQL

The NASDAQ 100 Pre-Market Indicator is down -2.35 to 2,741.83. The total Pre-Market volume is currently 2,879,057 shares traded. The following are the most active stocks for the pre-market... Read >>

Displaying 1-15 of 57
<< first < previous 1 2 3 4 next > last >>